Search Results
Sep 10, 2026, 09:00 ET Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Sep 03, 2026, 09:00 ET Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Sep 01, 2026, 09:30 ET Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Aug 18, 2026, 09:30 ET Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Aug 13, 2026, 16:01 ET Co-Diagnostics Reports Second Quarter 2026 Financial Results
SALT LAKE CITY, Aug. 13, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
More news about: Co-Diagnostics
Aug 06, 2026, 09:30 ET Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jul 30, 2026, 09:00 ET Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jul 28, 2026, 08:00 ET Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jul 22, 2026, 09:00 ET Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jul 16, 2026, 09:00 ET Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jul 08, 2026, 09:00 ET Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jul 01, 2026, 09:00 ET Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jun 25, 2026, 09:00 ET Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jun 18, 2026, 09:05 ET Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jun 11, 2026, 09:00 ET Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Jun 02, 2026, 09:00 ET Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
May 26, 2026, 09:00 ET Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
May 19, 2026, 22:54 ET Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
May 19, 2026, 09:00 ET Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
May 14, 2026, 16:01 ET Co-Diagnostics Reports First Quarter 2026 Financial Results
IPSALT LAKE CITY, May 14, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
More news about: Co-Diagnostics
May 08, 2026, 09:00 ET Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Apr 30, 2026, 09:00 ET Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today
More news about: Co-Diagnostics
Apr 16, 2026, 09:00 ET Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced
More news about: Co-Diagnostics
Apr 14, 2026, 09:00 ET Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced
More news about: Co-Diagnostics
Apr 09, 2026, 09:00 ET Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced
More news about: Co-Diagnostics